welcome
Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Business

Business & Economics

Mereo BioPharma Group plc (MREO): A Bull Case Theory

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
Summary
Nutrition label

77% Informative

Mereo BioPharma ( MREO ) appears to be one of the most mispriced biotech opportunities following the broader XBI sell-off, trading at $ 1.80 despite prior enthusiasm around $ 4.80 .

While undeniably speculative and high-risk, the core fundamentals remain unchanged.

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.